Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer

[1]  I. Ellis,et al.  Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer , 2014, BMC Cancer.

[2]  D. Lobo,et al.  Expression of the calpain system is associated with poor clinical outcome in gastro-oesophageal adenocarcinomas , 2013, Journal of Gastroenterology.

[3]  D. Lobo,et al.  Calpain system protein expression in carcinomas of the pancreas, bile duct and ampulla , 2012, BMC Cancer.

[4]  Stewart G. Martin,et al.  Calpain-2 expression is associated with response to platinum based chemotherapy, progression-free and overall survival in ovarian cancer , 2012, Journal of cellular and molecular medicine.

[5]  I. Ellis,et al.  Calpain system protein expression in basal-like and triple-negative invasive breast cancer , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[6]  Li Yang,et al.  17beta‐estradiol induces both up‐regulation and processing of cyclin E in a calpain‐dependent manner in MCF‐7 breast cancer cells , 2012, FEBS letters.

[7]  I. Ellis,et al.  Calpain‐1 expression is associated with relapse‐free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy , 2011, International journal of cancer.

[8]  G. Ball,et al.  Calpastatin is associated with lymphovascular invasion in breast cancer. , 2011, Breast.

[9]  Neil O. Carragher,et al.  The calpain system and cancer , 2011, Nature Reviews Cancer.

[10]  K. Sakimura,et al.  Calpain 8/nCL-2 and Calpain 9/nCL-4 Constitute an Active Protease Complex, G-Calpain, Involved in Gastric Mucosal Defense , 2010, PLoS genetics.

[11]  I. Ellis,et al.  The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers , 2010, The Journal of pathology.

[12]  J. Shively,et al.  Role of calpain-9 and PKC-delta in the apoptotic mechanism of lumen formation in CEACAM1 transfected breast epithelial cells. , 2010, Experimental cell research.

[13]  R. Jensen,et al.  Estrogen's and progesterone's impact on gene expression in the mouse lacrimal gland. , 2006, Investigative ophthalmology & visual science.

[14]  A. Harris,et al.  REporting recommendations for tumour MARKer prognostic studies (REMARK) , 2005, British Journal of Cancer.

[15]  D. Rimm,et al.  X-Tile , 2004, Clinical Cancer Research.

[16]  Minetta C. Liu,et al.  Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling , 2003, Oncogene.

[17]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[18]  E. J. Lee,et al.  Estrogen regulates a tissue-specific calpain in the anterior pituitary. , 2002, Biochemical and biophysical research communications.

[19]  S. Cohen,et al.  Antisense RNA-mediated Deficiency of the Calpain Protease, nCL-4, in NIH3T3 Cells Is Associated with Neoplastic Transformation and Tumorigenesis* , 2000, The Journal of Biological Chemistry.

[20]  Y. Yoshikawa,et al.  Isolation of Two Novel Genes, Down‐regulated in Gastric Cancer , 2000, Japanese journal of cancer research : Gann.

[21]  K. Suzuki,et al.  Characterization of a human digestive tract-specific calpain, nCL-4, expressed in the baculovirus system. , 1999, Archives of biochemistry and biophysics.

[22]  H. Koyama,et al.  Ca2+-dependent neutral protease (Calpain) activity in breast cancer tissue and estrogen receptor status , 1996, Breast cancer.